Sort
23,748 grants matching “melanoma”
Apoptosis in Melanoma Progression and Chemoresistance
$300,612University Of Michigan At Ann Arbor · R01 · FY2005 · CA
Apoptosis in Melanoma Progression and Chemoresistance
$300,612University Of Michigan At Ann Arbor · R01 · FY2004 · CA
Chemically Programmed Antibodies for Cancer Therapy
$300,594Carlos F Barbas · Scripps Research Institute, The · R01 · FY2006 · CA
Core 2: Animal and Pharmacology
$300,543Jann N Sarkaria · Massachusetts Institute Of Technology · U54 · FY2016 · CA
The Cancer Training Web -- A Multi-Institutional Tutoring System in Pathology
$300,511Rebecca S Crowley · University Of Pittsburgh At Pittsburgh · R25 · FY2009 · CA
CLINICAL DEVELOPMENT OF HU14.18 IL2 TARGETED THERAPY
$300,493University Of Wisconsin Madison · R01 · FY2002 · CA
US Detection of Sentinel Lymph Nodes in Melanoma
$300,492Thomas Jefferson University · R01 · FY2004 · CA
Apoptosis of skin melanoma by the new Hsp H11
$300,374Laure Aurelian · University Of Maryland Baltimore · R01 · FY2011 · AR
Stress-induced immunosuppression via downregulation of interferon in triple negative breast cancer
$300,357Shipra Gandhi · Emory University · K08 · FY2025 · CA
Regulatory T Cells and Toll-Like Receptor Signaling in Lymphoma Therapy
$300,320Wang Rongfu · Baylor College Of Medicine · P50 · FY2009 · CA
Discovery of Alpha-MSH Analogs for Skin Cancer Prevention
$300,311Zalfa Abdel-Malek · University Of Cincinnati · R01 · FY2008 · CA
Leukocyte-Endothelial Adhesion in Tumor Immunity
$300,266Sharon S Evans · Roswell Park Cancer Institute Corp · R01 · FY2013 · CA
ANTIBODY-TARGETED POLYMERIC SYSTEMS FOR TUMOR IMAGING
$300,263Northeastern University · R01 · FY2005 · EB
Engineered T Cell Therapy for Melanoma
$300,231Robert H Vonderheide · Wistar Institute · P50 · FY2015 · CA
LPD Nanoparticles in Anti-Cancer Therapy
$300,211Leaf Huang · Univ Of North Carolina Chapel Hill · R01 · FY2008 · CA
Targeting the NF-kappaB Pathway in Melanoma
$300,200Vanderbilt University · R01 · FY2005 · CA
Gene Therapy for Human Malignant Melanoma
$300,183Elizabeth A Grimm · Introgen Research Institute, Inc. · R42 · FY2006 · CA
Environmentally-modulated cytosine deamination in genome instability and cancer
$300,173Steven A Roberts · Washington State University · R00 · FY2017 · ES
Mechanisms of Inhibitors of MRTF/SRF-regulated Gene Transcription
$300,169Richard R Neubig · Michigan State University · R01 · FY2018 · GM
Mechanisms of Inhibitors of MRTF/SRF-regulated Gene Transcription
$300,169Richard R Neubig · Michigan State University · R01 · FY2017 · GM
Association of Inherited Variation in Immune Mediated Adverse Events and Respons
$300,167Katherine L Nathanson · Wistar Institute · P50 · FY2014 · CA
Innate Mechanisms Regulating CD8+ T Cell Immunity
$300,039Robert Fairchild · Cleveland Clinic Lerner Com-Cwru · R01 · FY2007 · AI
Durable CD4+ T-cell Tumor Immunity Following Gene-modified HPSC
$300,018Christopher E. Touloukian · Indiana University Indianapolis · R01 · FY2009 · CA
Angiogenesis antagonist plus CD40-TLR agonist adjuvant combination vaccine
$300,000Susan Dana Jones · Immurx Llc · R43 · FY2010 · AI
Novel Therapeutic Vaccines for Chronic HBV
$300,000Robert Gerald Whalen · Altravax, Inc. · R43 · FY2013 · AI